BMJ  2003;326 (31 May), doi:10.1136/bmj.326.7400.0-b

Drug representatives may increase unnecessary GP prescribing

General practitioners who see drug companies' representatives at least once a week are more likely to express views that lead to unnecessary prescribing. In a questionnaire survey of the attitudes and behaviours of general practitioners throughout England in relation to their prescribing rates, Watkins and colleagues found that practitioners with the greatest contact with drug representatives were most willing to prescribe new drugs and to comply with patients' requests for drugs that are not clinically indicated (p 1178). The doctors who saw drug representatives most frequently tended to be singlehanded practitioners, did not provide postgraduate training, and worked in deprived areas.

CSA PLASTOCK/PHOTONICA

Related Article

Characteristics of general practitioners who frequently see drug industry representatives: national cross sectional study
Chris Watkins, Laurence Moore, Ian Harvey, Patricia Carthy, Elizabeth Robinson, and Richard Brawn
BMJ 2003 326: 1178-1179. [Full Text] [PDF]


Online poll
Find out more

Rapid responses for this article

There are no rapid responses for this article.


Student BMJ

Risk of surgery for inflammatory bowel disease: record linkage studies

What can you learn from this BMJ paper? Read Leanne Tite's Paper+

www.student.bmj.com

Listen to the latest BMJ Interview